Hat mitgewirkt an:
-
Untersuchungen des dualen Topoisomerase-Inhibitors P8-D6 für die Therapie gynäkologischer Tumore
-
ADAM17 Inhibition Increases the Impact of Cisplatin Treatment in Ovarian Cancer Spheroids
-
Combined PARP and Dual Topoisomerase Inhibition Potentiates Genome Instability and Cell Death in Ovarian Cancer
-
High Antitumor Activity of the Dual Topoisomerase Inhibitor P8-D6 in Breast Cancer